Michel Vallée

5.7k total citations
48 papers, 724 citations indexed

About

Michel Vallée is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Michel Vallée has authored 48 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Genetics. Recurrent topics in Michel Vallée's work include Dialysis and Renal Disease Management (9 papers), Parathyroid Disorders and Treatments (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Michel Vallée is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Parathyroid Disorders and Treatments (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Michel Vallée collaborates with scholars based in Canada, Switzerland and France. Michel Vallée's co-authors include Alain Bélanger, Caroline Albert, Dean W. Hum, Jean‐Philippe Lafrance, Louis‐Philippe Laurin, Denis Ouimet, Vincent Pichette, Naoual Elftouh, Olivier Barbier and Yves Tremblay and has published in prestigious journals such as SHILAP Revista de lepidopterología, Endocrinology and Molecular Pharmacology.

In The Last Decade

Michel Vallée

46 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Vallée Canada 12 168 160 153 143 130 48 724
Houssem Hmouda Tunisia 10 144 0.9× 126 0.8× 35 0.2× 95 0.7× 119 0.9× 20 593
Uri Pollak Israel 11 151 0.9× 81 0.5× 73 0.5× 225 1.6× 37 0.3× 28 753
Mark A. Klausner United States 14 446 2.7× 125 0.8× 30 0.2× 118 0.8× 53 0.4× 24 1.2k
Ajay P. Sharma Canada 20 282 1.7× 131 0.8× 18 0.1× 137 1.0× 60 0.5× 57 1.1k
Joanna Q. Hudson United States 18 218 1.3× 92 0.6× 19 0.1× 106 0.7× 36 0.3× 60 897
Arnošt Martínek Czechia 15 174 1.0× 190 1.2× 22 0.1× 185 1.3× 35 0.3× 56 942
T Talseth Norway 19 80 0.5× 101 0.6× 94 0.6× 136 1.0× 52 0.4× 57 1.4k
C. P. Swainson United Kingdom 14 113 0.7× 92 0.6× 144 0.9× 88 0.6× 54 0.4× 43 680
Samir Mallat Lebanon 18 195 1.2× 66 0.4× 20 0.1× 131 0.9× 67 0.5× 41 911
B. Peter Sawaya United States 17 442 2.6× 129 0.8× 21 0.1× 75 0.5× 62 0.5× 34 952

Countries citing papers authored by Michel Vallée

Since Specialization
Citations

This map shows the geographic impact of Michel Vallée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Vallée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Vallée more than expected).

Fields of papers citing papers by Michel Vallée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Vallée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Vallée. The network helps show where Michel Vallée may publish in the future.

Co-authorship network of co-authors of Michel Vallée

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Vallée. A scholar is included among the top collaborators of Michel Vallée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Vallée. Michel Vallée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallée, Michel, et al.. (2021). Multidisciplinary Perspectives of Current Approaches and Clinical Gaps in the Management of Hyperphosphatemia. International Journal of Nephrology and Renovascular Disease. Volume 14. 301–311. 4 indexed citations
2.
Goupil, Rémi, Maxime Lamarre-Cliché, & Michel Vallée. (2018). The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications. Canadian Journal of Cardiology. 34(5). 665–669. 9 indexed citations
3.
Vallée, Michel, et al.. (2018). Single-Pill Combinations in the Treatment of Hypertension in Adults: Beyond Convenience. Canadian Journal of Diabetes. 42(2). 205–208. 3 indexed citations
4.
Lafrance, Jean‐Philippe, Vincent Pichette, Georges Ouellet, et al.. (2016). Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients. International Urology and Nephrology. 49(2). 325–328. 6 indexed citations
5.
Beaubien–Souligny, William, Vincent Pichette, Jean‐Philippe Lafrance, et al.. (2015). The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D. International Urology and Nephrology. 47(7). 1165–1171. 3 indexed citations
6.
Vallée, Michel, et al.. (2015). Presumed paradoxical embolus in a patient with diabetic ketoacidosis. International Journal of General Medicine. 8. 297–297.
7.
Bell, Robert L., Michel Vallée, Michel Savoie, et al.. (2015). Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD. Clinical Journal of the American Society of Nephrology. 10(12). 2136–2142. 115 indexed citations
8.
Pietzsch, Jan B., et al.. (2013). Cost-effectiveness of catheter-based renal denervation for resistant hypertension – a canadian perspective. Value in Health. 16(3). A284–A285. 1 indexed citations
9.
Lafrance, Jean‐Philippe, Elham Rahme, Sameena Iqbal, et al.. (2012). Association of Dialysis Modality with Risk for Infection-Related Hospitalization. Clinical Journal of the American Society of Nephrology. 7(10). 1598–1605. 41 indexed citations
10.
Vallée, Michel & Tullio Caputo. (2011). Crime prevention and community safety for children and youth in Canada. 2 indexed citations
11.
Nadeau‐Fredette, Annie‐Claire, et al.. (2011). Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. International Journal of Infectious Diseases. 16(1). e41–e43. 27 indexed citations
12.
Bouchard, Josée, Denis Ouimet, Michel Vallée, et al.. (2008). Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations. International Urology and Nephrology. 41(4). 983–988. 7 indexed citations
13.
Rabi, Doreen M., Nadia Khan, Michel Vallée, et al.. (2008). Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy. Canadian Journal of Cardiology. 24(6). 491–496. 44 indexed citations
14.
Vallée, Michel, et al.. (2008). High mortality after pelvis and lower limb fractures in ESRD. Clinical Kidney Journal. 1(6). 466–466. 4 indexed citations
15.
Barbier, Olivier, Caroline Albert, Isabelle Martineau, et al.. (2001). Glucuronidation of the Nonsteroidal Antiestrogen EM-652 (SCH 57068), by Human and Monkey Steroid Conjugating UDP-Glucuronosyltransferase Enzymes. Molecular Pharmacology. 59(3). 636–645. 15 indexed citations
16.
Vallée, Michel, et al.. (2001). Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens. The Journal of Steroid Biochemistry and Molecular Biology. 77(4-5). 239–249. 10 indexed citations
17.
18.
Hum, Dean W., Alain Bélanger, Éric Lévesque, et al.. (1999). Characterization of UDP-glucuronosyltransferases active on steroid hormones. The Journal of Steroid Biochemistry and Molecular Biology. 69(1-6). 413–423. 95 indexed citations
19.
Bélanger, Alain, et al.. (1995). Regulation of 21-Hydroxylase activity by steroids. Endocrine Research. 21(1-2). 329–341. 4 indexed citations
20.
Vallée, Michel, et al.. (1995). Regulation of guinea pig adrenal P450c21 messenger RNA, protein and activity by RU486. The Journal of Steroid Biochemistry and Molecular Biology. 54(1-2). 31–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Houssem Hmouda Breakdown of academic impact, for papers by Uri Pollak Breakdown of academic impact, for papers by Mark A. Klausner Breakdown of academic impact, for papers by Ajay P. Sharma Breakdown of academic impact, for papers by Joanna Q. Hudson Breakdown of academic impact, for papers by Arnošt Martínek Breakdown of academic impact, for papers by T Talseth Breakdown of academic impact, for papers by C. P. Swainson Breakdown of academic impact, for papers by Samir Mallat Breakdown of academic impact, for papers by B. Peter Sawaya
Rankless by CCL
2026